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Abstract
Aims: The objective of this study was to estimate UV254 inactivation constants for four viral pathogens:
influenza virus type A, porcine respiratory and reproductive syndrome virus (PRRSV), bovine viral diarrhoea
virus (BVDV) and reovirus.
Methods and Results: Viruses in culture medium were exposed to one of nine doses of UV254 and then
titrated for infectious virus. Analysis showed that viral inactivation by UV254 was more accurately described
by a two-stage inactivation model vs a standard one-stage inactivation model.
Conclusions: The results provided evidence for the existence of two heterogeneous viral subpopulations
among the viruses tested, one highly susceptible to UV254 inactivation and the other more resistant.
Importantly, inactivation constants based on the one-stage inactivation model would have underestimated the
UV254 dose required for the inactivation of these viruses under the conditions of the experiment.
Significance and Impact of the Study: To improve the accuracy of estimates, it is recommended that
research involving the inactivation of micro-organisms evaluates inactivation kinetics using both one-stage
and two-stage models. These results will be of interest to persons responsible for microbial agents under
laboratory or field conditions.
Keywords
PRRSV, Two stage, Ultraviolet, UV inactivation
Disciplines
Animal Diseases | Biometry | Bioresource and Agricultural Engineering | Large or Food Animal and Equine
Medicine | Veterinary Infectious Diseases | Veterinary Microbiology and Immunobiology
Comments
This article is from Journal of Applied Microbiology 111 (2011): 389–395, doi:10.1111/
j.1365-2672.2011.05046.x. Posted with permission.
Rights
Works produced by employees of the U.S. Government as part of their official duties are not copyrighted
within the U.S. The content of this document is not copyrighted.
Authors
T. Cutler, C. Wang, Q. Qin, F. Zhou, K. Warren, K.-J. Yoon, S. J. Hoff, J. Ridpath, and J. Zimmerman
This article is available at Iowa State University Digital Repository: http://lib.dr.iastate.edu/vdpam_pubs/65
ORIGINAL ARTICLE
Kinetics of UV254 inactivation of selected viral pathogens in
a static system
T. Cutler1, C. Wang1,2, Q. Qin3, F. Zhou1, K. Warren1, K.-J. Yoon1, S.J. Hoff4, J. Ridpath5
and J. Zimmerman1
1 Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, USA
2 Department of Statistics, Iowa State University, Ames, IA, USA
3 Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA, USA
4 Department of Agriculture and Biosystems Engineering, Iowa State University, Ames, IA, USA
5 USDA:ARS:NADC, Ames, IA, USA
Introduction
Ultraviolet (UV) radiation is the part of the electromag-
netic spectrum that lays between the high-energy X-rays
(£100 nm) and the visible spectrum (>400 nm). UV254
inactivation has been a proven method of disinfection
since 1930s (Brickner et al. 2003). In 1960s, it was shown
that inactivation of microbes occurred through dimer
formation by nucleic acids, with 260 nm determined to
be the UV wavelength most efficiently absorbed by
genetic material (Kowalski et al. 2001).
The efficacy of UV inactivation is dependent upon sev-
eral factors, including the microbe’s susceptibility to
UV254. Microbial susceptibility to UV254, generally termed
the inactivation constant (k), is frequently modelled using
the following Eqn (1):
k ¼
log10
Nt
N0
 
Dose
ð1Þ
where
k = the inactivation constant
N0 = quantity of microbes at time zero
Nt = quantity of microbes at UV254 exposure time ‘t’
Doset = depth (centimetres) of the solution irradiated
by UV254
Thus, the one-stage inactivation model (Eqn 1) describes
the one-hit model which, when log10-transformed, is
described by a linear relationship between the survival
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Abstract
Aims: The objective of this study was to estimate UV254 inactivation constants
for four viral pathogens: influenza virus type A, porcine respiratory and repro-
ductive syndrome virus (PRRSV), bovine viral diarrhoea virus (BVDV) and
reovirus.
Methods and Results: Viruses in culture medium were exposed to one of nine
doses of UV254 and then titrated for infectious virus. Analysis showed that viral
inactivation by UV254 was more accurately described by a two-stage inactiva-
tion model vs a standard one-stage inactivation model.
Conclusions: The results provided evidence for the existence of two heteroge-
neous viral subpopulations among the viruses tested, one highly susceptible to
UV254 inactivation and the other more resistant. Importantly, inactivation con-
stants based on the one-stage inactivation model would have underestimated
the UV254 dose required for the inactivation of these viruses under the condi-
tions of the experiment.
Significance and Impact of the Study: To improve the accuracy of estimates, it
is recommended that research involving the inactivation of micro-organisms
evaluates inactivation kinetics using both one-stage and two-stage models.
These results will be of interest to persons responsible for microbial agents
under laboratory or field conditions.
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fraction of the microbial population and the UV254 expo-
sure dose (Goldberg et al. 1958). This model long served
as the primary method for describing microbial suscepti-
bility to UV254. In 1964, Hiatt described the limitations of
the model and proposed several alternate computational
models to describe the inactivation of microbes (Hiatt
1964). More recently, Kowalski et al. (2001) described a
two-stage inactivation model for UV254 inactivation of
viruses. The objectives of this study were to compare the
one-stage and two-stage inactivation models and report
the inactivation constants for two enveloped (+)ssRNA
viruses [porcine respiratory and reproductive syndrome
virus (PRRSV) and bovine viral diarrhoea virus (BVDV)],
an enveloped ())ssRNA virus (influenza virus type A) and
a nonenveloped dsRNA virus (reovirus) in a static envi-
ronment. The viruses chosen include economically signifi-
cant animal pathogens for which estimates of UV254
inactivation are not available.
Materials and methods
Experimental design
Viruses were suspended in culture medium and exposed
to specific doses of UV254 by placing aliquots into wells
of a modified 8-well plate (VWR, West Chester, PA,
USA). Each plate included a positive control virus
(BVDV, PRRSV, reovirus or influenza) that was protected
from UV254 exposure by covering the well with aluminium
foil. To reduce bias, the placement of each virus within
the plate, the unexposed viral control for each plate and
the UV254 dose for each plate were randomized. Follow-
ing UV254 exposure, the samples were harvested and
stored at )80C until titrated for infectious virus. Viral
inactivation data were analysed using both the one-stage
inactivation and two-stage inactivation models (Goldberg
et al. 1958; Kowalski et al. 2001).
Viruses
Influenza virus
Influenza A ⁄ Swine ⁄ Iowa ⁄ 73 (H1N1) (USDA: National
Veterinary Service Laboratories, Ames, IA, USA) was
propagated on Madin–Darby canine kidney (MDCK) cells
(American Type Culture Collection (ATCC), Manassas,
VA, USA). Cells were grown in 162-cm2 flasks (Corning,
Corning, NY, USA) using Dulbecco’s modified Eagle’s
medium (DMEM) (Mediatech Inc., Manassas, VA, USA)
supplemented with 0Æ25 lg ml)1 amphotericin B (Sigma
Chemical Co., St Louis, MO, USA), 50 lg ml)1 gentamycin
(Sigma Chemical Co.), 0Æ5 mol l)1 l-glutamine (Gibco,
Carlsbad, CA, USA), 300 international units (IU) ml)1
penicillin (Sigma), 300 lg ml)1 streptomycin (Sigma),
1Æ0% nonessential amino acids (HyClone, Logan, UT, USA),
25 mmol l)1 HEPES buffer (Sigma) and 10Æ0% heat-inacti-
vated foetal bovine serum (FBS) (Sigma, verified BVDV
free). When cells were confluent, the media were discarded
and the flasks rinsed with 15 ml of complete infecting med-
ium (CIM): 500 ml of DMEM growthmedium, 7Æ8% bovine
serum albumin (BSA) (Sigma) in place of 10% FBS, and
0Æ83 ml of trypsin working stock. Trypsin working stock was
formulated at 100 mg of l-(tosylamido-2-phenyl) ethyl chlo-
romethylketone (TPCK-treated) trypsin (Worthington Bio-
chemical, Lakewood, NJ, USA) diluted into 100 ml of CIM.
Flasks were inoculated with 5 ml of CIM containing SIV at a
titre of 1Æ26 · 106 TCID50 ml)1 and placed on a rocking
platform in a 37C humidified 5% CO2 incubator for
90 min, after which the inoculum was discarded and
replaced with 50 ml of maintenancemedium (MM): DMEM
growth medium with 4% heat-inactivated FBS in place of
10% FBS. Flasks were incubated at 37C in a humidified 5%
CO2 incubator and cells examined daily for cytopathic effect
(CPE). When ‡75% CPE was observed, flasks were freeze-
thawed and the cell lysate was harvested. The harvested lysate
was centrifuged at 10 000 g for 20 min at 4C and decanted,
and the supernatant was stored at)80C.
Porcine reproductive and respiratory syndrome virus
A type 2 PRRSV isolate MN-184 (provided by Dr Scott
Dee, University of Minnesota) was propagated in MARC-
145 cells (Iowa State University, Veterinary Diagnostic
Laboratory, Ames, IA, USA), and confluent cells were
inoculated with 5 ml of MN-184 virus at a titre of
1 · 103Æ5 TCID50 ml)1. The flasks were placed on a rock-
ing platform in a 37C humidified 5% CO2 incubator for
90 min, then 40 ml of DMEM growth medium with 4%
heat-inactivated FBS in place of 10% FBS was added, and
the flasks were returned to the incubator for 36 h. Cell
culture supernatant was harvested by flask freeze ⁄ thaw
and centrifugation (10 000 g for 20 min at 4C). Viral
stock was stored in 25-ml aliquots at )80C.
Bovine viral diarrhoea virus
Singer strain BVDV type 2 (provided by Dr J. Ridpath,
USDA: NADC) was propagated on bovine turbinate cell line
T7 (provided by Dr J. Ridpath, USDA: NADC). The cells
were grown in 162-cm2 flasks using EME growth medium:
EME medium (Sigma) containing 0Æ25 lg ml)1 amphoteri-
cin B (Sigma), 50 lg ml)1 gentamycin (Sigma),
300 IU ml)1 penicillin (Sigma), 300 lg ml)1 streptomycin
(Sigma) and 10% FBS (Sigma, verified BVDV free). When
cells were 75% confluent, the media were discarded and the
flasks inoculated with 5 ml of EME growth medium con-
taining BVDV at a titre of 1Æ26 · 106 TCID50 ml)1 and
placed on a rocking platform in a 37C humidified 5% CO2
incubator for 90 min. Thereafter, 40 ml of EME growth
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medium was added and the cells were examined daily for
CPE. When c. 75% CPE was observed, cell culture superna-
tant was harvested by flask freeze ⁄ thaw and centrifugation
(10 000 g for 20 min at 4C). Viral stock was stored in 25-
ml aliquots at )80C.
Reovirus
Reovirus strain T3DC (provided by Dr Cathy Miller, Iowa
State University) was propagated in spinner culture-
adapted murine fibroblasts (L929 cells) as described by Qin
et al. (2009). Confluent L929 cells were incubated with a
multiplicity of infection of ten plaque-forming units per
cell in Joklik c-MEM (Sigma) and stirred for 3 days at
35C. Thereafter, the cells were pelleted, the supernatant
was discarded, and the pellet was resuspended in an equal
volume of fresh media. The resuspended cells were soni-
cated, as described by Nibert and Fields (1992), and then
centrifuged at 3000 g for 5 min. The supernatant was
adjusted to a viral concentration of 1Æ7 · 109 PFU ml)1
with Joklik c-MEM media and stored at 4C until used.
Viral titration
Samples were assayed for infectious virus following the
procedures described in the following paragraph. To
avoid bias, sample aliquots were assayed blind and in
random order. Viral titres were calculated using the
Spearman–Ka¨rber method and expressed as the median
tissue culture infective dose (TCID50) ml
)1 (Hubert 1992).
Influenza virus microinfectivity and hemagglutination
assays
Swine testicle (ST) cells (ATCC CRL-1746) were propagated
in 96-well tissue culture plates (Costar, Corning, NY, USA)
using MEM growth medium: (MEM) minimum essential
Eagle’s medium (Sigma) containing 0Æ25 lg ml)1 ampho-
tericin B (Sigma), 50 lg ml)1 gentamycin (Sigma),
2 mmol l)1 l-glutamine (Sigma), 100 IU ml)1 penicillin
(Sigma), 100 lg ml)1 streptomycin (Sigma) and 10%
heat-inactivated FBS (Atlas, Fort Collins, CO, USA).
Duplicate samples were serially tenfold diluted (10)1–
10)6) in MEM growth medium with 2% heat-inactivated
FBS in place of 10% FBS. Test and control sample serial
dilutions were plated at 100 ll per well onto confluent
cells. Plates were incubated in a 37C humidified 5% CO2
incubator and observed daily, when ‡50% CPE was
observed, or at the end of the 7-day incubation, the plates
were frozen at )80C.
All test wells were HA tested for confirmation using a
hemagglutination (HA) assay. In brief, 50 ll of positive
control [Influenza A ⁄ Swine ⁄ Iowa ⁄ 73 (H1N1)], negative
control (1· PBS, pH = 7Æ2) and fluid from free-
ze ⁄ thawed CPE-positive wells was added to an untreated
96-well round bottom microtitration plate (Evergreen
Scientific, Los Angeles, CA, USA) and serially twofold
diluted (1 : 2 to 1 : 256) in 1· PBS. Thereafter, 50 ll of
0Æ55% turkey red blood cells (USDA: NVSL) was added
to each well, and the plates were incubated for 30 min
at 25C. A positive reaction produced red blood cell
agglutination, i.e. a ‘mat’ at the bottom of the well.
Samples demonstrating CPE on the microinfectivity
assay and an HA viral titre ‡1 : 4 were considered posi-
tive for infectious SIV. Viral titres were calculated on
the basis of the number of wells in the microinfectivity
assay showing CPE. Each sample was run in duplicate
with the titres averaged.
Porcine reproductive and respiratory syndrome virus
microinfectivity assay
MARC-145 cells propagated in 96-well tissue culture plates
(Corning) using DMEM growth medium were incubated at
37C in a humidified 5% CO2 incubator for 72 h. Samples
to be assayed were serially tenfold diluted (10)1–10)5) in
DMEM growth medium without FBS. The growth medium
was discarded, and five wells were inoculated with 100 ll of
sample at each dilution. The plates were placed in a 37C
humidified 5% CO2 incubator for 90 min, the inoculum
was discarded, and 100 ll per well of growth medium con-
taining 4% FBS, rather than 10% FBS, was added to each
well. Plates were incubated at 37C in a humidified 5%
CO2 incubator for 24 h. Following incubation, cells were
fixed with cold 80% acetone ⁄water solution and stained for
30 min at 37C with SDOW-17F, fluorescein isothiocya-
nate–conjugated monoclonal antibody specific for PRRSV
diluted, according to manufacturer’s instructions (Rural
Technologies Inc., Brookings, SD, USA). Viral titres were
calculated on the basis of the number of wells showing a
PRRSV-specific fluorescence reaction at each dilution. Each
sample was run in triplicate and the titres were averaged.
Bovine viral diarrhoea virus microinfectivity assay
Madin–Darby bovine kidney cells (MDBK), (ATCC) were
propagated in 96-well plates (Costar) using complete
Ex-Cell MDBK-MM Medium (Sigma) containing
0Æ25 lg ml)1 amphotericin B (Sigma), 50 lg ml)1 genta-
mycin (Sigma), 2 mmol l)1 l-glutamine (Sigma), 100 IU ml)1
penicillin (Sigma), 100 lg ml)1 streptomycin (Sigma) and
5% heat-inactivated equine serum (HyClone). Plates were
incubated at 37C in a humidified 5% CO2 incubator
until the cell monolayer was confluent. Samples were seri-
ally tenfold diluted (10)1–10)6) in complete Ex-Cell
MDBK-MM Medium, and 100 ll per well of each sample
dilution was applied over the cell suspension. Plates were
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then incubated at 37C in a humidified 5% CO2 incuba-
tor for 24 h, and then, the growth medium was replaced
with 200 ll per well of complete medium. The plates
were returned to the incubator for an additional 24 h and
viewed for CPE. The plates were then frozen at )80C
until confirmatory testing to be carried out. Confirmatory
testing and genotyping of BVDV results were carried out
using RT-PCR with visualization on a 2% agarose gel
(Ameresco, Solon, OH, USA). The viral RNA was
extracted as per the manufacturer’s specifications, using
the Ambion MagMAX-96 Viral RNA Isolation kit
(Ambion, Austin, TX, USA), reverse-transcribed and
amplified using the Qiagen One-Step RT-PCR kit
(Qiagen, Valencia, CA, USA). Thermal cycling conditions
were as follows: 50C for 30 min, melt at 95C for
15 min, 35 cycles of amplification at 94C for 30 s, 50C
for 30 s, 72C for 1 min and extension for 10 min at
72C. Primers used were 5¢-TCGACGCCTTRRCAT-
GAAGGT-3¢ and 5¢-TCGACGCTTTGGAGGACAAGC-3¢.
The 180-basepair product was run on a 2% agarose gel
and visualized under UV illumination.
Reovirus plaque assay
L929 cells in Joklik’s minimum essential medium (Sigma)
containing 10% FBS (Atlanta Biological, Lawrenceville,
GA, USA) were added to 6-well plates (Corning) at a con-
centration of 2 · 106 cells per well and incubated at 37C
overnight. Thereafter, the medium was removed and the
cells were washed once with sterile 1· PBS. To conduct the
assay, the sample was serially diluted tenfold, and 100 ll
per well was added and allowed to adsorb for 1 h at 25C.
The wells were then overlaid with 2 ml of complete 1·
Medium 199 at 37C. Overlay was formulated as 2· Med-
ium 199 (Sigma) containing 4 mmol l)1 ml)1 l-glutamine
(Mediatech), 200 IU ml)1 penicillin, 200 lg ml)1 strepto-
mycin (Mediatech) and 20 lg ml)1 trypsin (Mediatech) to
which was added an equal volume of 58C 2% agar (BD
Bacto, Franklin Lakes, NJ, USA). The plates were incu-
bated for 48 h in a 37C humidified 5% CO2 incubator
prior to counting plaques.
Exposure of viruses to ultraviolet (UV254)
Source of ultraviolet
The UV254-emitting apparatus consisted of an 18-inch
(46 cm), 2-lamp, surface-mounted, 110-volt, Ultraviolet
fixture (American UV Company, Lebanon, IN, USA)
fitted with two standard output, quasi-collimated beam,
low-pressure, mercury vapour germicidal lamps emitting
monochromatic UV radiation at 253Æ7 nm (American UV
Company). For uniform output, the lamps were ‘burned
in’ for 8 h prior to use. The UV254 source was mounted
within an environmental chamber capable of maintaining
a constant temperature of 4C (Percival Scientific, Perry,
IA, USA). The inside of the environmental chamber was
draped with black burlap to eliminate the reflection of
the UV254. To allow lamps to reach full operating pres-
sure within the 4C environmental chamber, UV-emitting
lamps were turned on 2 h prior to commencing the irra-
diation experiment and 20 min before each exposure
treatment, thereafter.
Viral exposure to ultraviolet
Prior to UV254 exposure, the clarified viral solutions were
thawed and mixed thoroughly to disperse viral aggregates.
Initial concentrations of 1 · 108Æ4 (BVDV), 1 · 106Æ0
(PRRSV), 1 · 106Æ0 (influenza virus) and 1 · 109Æ5 (reo-
virus) TCID50 ml
)1 were exposed to specific UV254 doses
(25, 50, 75, 100, 125, 150, 200, 250 and 300 mJ cm)2) by
placing aliquots (2 mm depth) of each virus into four
separate wells. One positive control virus (either influenza
virus type A, PRRSV, BVDV or reovirus) was placed in a
covered fifth well. The UV254 exposure dose
(intensity · time) was determined using the integration
function of two commercial radiometers equipped with
UV254 sensors (Technika, Scottsdale, AZ, USA). The
UV254 doses (n = 9) were replicated five times, which
corresponded to 45 plates.
To achieve the predetermined sample exposure dose,
the two centre wells in one row of each plate were
removed to accommodate a UV254 sensor. The viruses
were exposed to UV254 by the use of an electronically
controlled shutter system. After lamp warm-up (20 min),
the shutters were opened and the plate was exposed to
the target dose. When the dose was reached, the UV254
emitter was shut off, the shutter system reset, the next
plate placed in the environmental chamber, and the
UV254 emitters warmed up for 20 min prior to exposure.
Following UV254 exposure, each viral suspension was
harvested using a pipette, placed in a 2-ml storage vial
labelled with the viral species and a random number and
frozen at )80C until titrated for infectious virus.
In accordance with the Lambert–Beer’s Law, the absor-
bance of any UV254 by the liquid medium was deter-
mined by measurements taken at the top of the 2 mm
depth of the sample and beneath a quartz cuvette con-
taining an equal (2 mm) depth of medium. The measured
intensity was corrected for absorbance by the viral med-
ium using Eqn 2 (Thurston-Enriquez et al. 2003):
Iaverage ¼ I0ð1e
aeLÞ
aeL
ð2Þ
where
Iaverage = average UV254 intensity (mW cm
)2)
ae = absorbance of the viral suspension to the base e
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392 Journal of Applied Microbiology 111, 389–395 ª 2011 The Society for Applied Microbiology
ª 2011 The Authors
I0 = UV254 intensity after passing through solution
L = depth (centimetres) of the solution irradiated by the
UV254 energy.
Statistical analysis
Two statistical models were used for analysing the UV254
inactivation of each virus.
Model 1. The one-stage inactivation model (Eqn 1)
assumed uniform susceptibility of the viral population
and utilized simple linear regression (Eqn 3), with the
log-transformed viral concentration as the response and
the dose of UV254 as the explanatory variable:
log10Nt ¼ log10N0k  Doset ð3Þ
where
Nt = quantity of virus in the test sample after treatment
with Doset
N0 = quantity of virus in the unexposed control sample
k = the inactivation rate
Doset = average UV254 intensity · time
In the one-stage inactivation model, the inactivation
constant (k) is the quotient of the survival fraction
Nt
N0
 
plotted against the dose. This linear regression
model encompasses all of the data points and forces the
points into one curve using the classic regression formula,
b ¼ mxy
 
.
Model 2. The two-stage inactivation model (Eqn 4)
assumed two heterogeneous subpopulations: one relatively
susceptible and the other relatively resistant to UV254
treatment (Nibert and Fields 1992):
log10Nt ¼ log10N0 þ log10½ð1f Þ  10k1Doset
þ f 10k2Doset  ð4Þ
where
Nt = quantity of virus in the test sample after treatment
with Doset
N0 = quantity of virus in the unexposed control sample
f = the resistant fraction of the total initial viral popula-
tion with inactivation rate k2
(1 ) f) = the susceptible viral population fraction with
inactivation rate k1
k1 = the inactivation rate of the inactivation curve for
the ‘fast decay population’
k2 = the inactivation rate of the inactivation curve for
the ‘resistant population’
Doset = average UV254 intensity · time
The two-stage inactivation model provides two inactiva-
tion constants based on the quotient of the survival
fractions of two separate microbial populations: the
UV-susceptible population and the resistant population.
The susceptible population (1 ) f) has an inactivation
constant of (k1); the resistant population (f) has an inacti-
vation constant of (k2).
The analysis of the data was conducted using sas ver.
9.2 (SAS Institute Inc., Cary, NC, USA). Simple linear
regression analysis was performed for Model 1 using sas
procedure GLM, and nonlinear regression analysis was
performed for Model 2 using sas procedure NLIN.
Lack-of-fit F tests were performed to assess whether the
two models fit the data adequately well, by comparing
with a full anova model. A P-value £0Æ05 was considered
significant.
Results
Analysis of the data showed that the one-stage inactivation
model did not fit the data (Table 1). Specifically,
the lack-of-fit tests for influenza virus (P = 0Æ0009), PRRSV
(P = 0Æ0002), BVDV (P < 0Æ0001) and reovirus
(P = 0Æ0410) showed a statistically significant difference
between the observed variation in the data and the variation
explained by the single curve model for each virus. Because
of the lack of fit, the inactivation constants (k) derived from
the one-stage inactivation analysis cannot accurately
describe the amount of UV254 needed for the inactivation
of these viruses under the conditions of the study.
Further analysis of the data showed a good fit between
the observed variation in data and the variation explained
by the two-stage inactivation model with lack-of-fit-test P-
values >0Æ05 for all viruses (Table 1). The two-stage model
described inactivation curves composed of two slopes sep-
arated by an inflection point denoting the inactivation
kinetics of the two viral populations (Figs 1–4). The two-
stage inactivation analysis estimated the susceptible popu-
lation (1 ) f) as 98Æ8% (influenza virus), 94Æ1% (PRRSV),
99Æ9% (BVDV) and 87Æ3% (reovirus) of the total viral
population. Inactivation rates (k1) in the susceptible popu-
lation were calculated as 0Æ0651 (influenza virus), 0Æ4995
(PRRSV), 0Æ0663 (BVDV) and 0Æ0142 (reovirus). The
resistant population (f) was a low proportion of the total
population of influenza virus (1Æ2%), PRRSV (5Æ9%) and
BVDV (0Æ07%), but a larger proportion of the reoviral
population (12Æ7%). Compared with the UV254-susceptible
population, the resistant populations showed lower inacti-
vation constants (k2), i.e. 0Æ0055 (influenza virus), 0Æ0143
(PRRSV), 0Æ0095 (BVDV) and 0Æ0035 (reovirus).
Discussion
Chick’s law describes the rate of microbial inactivation as
the ratio of the viable population (Nt) to the original
microbial population (N0) in relation to exposure time (t)
to an inactivator (Rubin and Elmaraghy 1977). The result-
ing one-stage inactivation constant (slope) is an estimate of
T. Cutler et al. UV254 inactivation of viral pathogens
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the rate of microbial inactivation based on the assumption
of a linear relationship between microbial inactivation and
contact time. This relationship has been used to describe
the kinetics of microbial populations under a variety of
inactivating conditions, including exposure to UV254 irra-
diation (Chang et al. 1985; Kowalski et al. 2001; Thurston-
Enriquez et al. 2003). One-stage inactivation estimates may
be accurate for describing UV254 inactivation in homoge-
nous microbial populations (Hiatt 1964). However, one-
stage estimates do not address the problem of ‘tailing off’
of UV inactivation curves and may overestimate the rate of
inactivation (Hiatt 1964; Hijnen et al. 2006). Jagger (1967)
hypothesized that microbial populations were actually
composed of two subpopulations: a larger UV254-suscepti-
ble population and a smaller UV254-resistant population.
Others have hypothesized that the UV-resistant population
reflects differences in viral clumping, sample preparation,
viral coat structure or viral genomics (Thurston-Enriquez
et al. 2003). Regardless of the mechanism, Riley and
Kaufman (1972) proposed an equation that accurately
described the UV254 inactivation of Serratia marcescens as a
two-stage process. Perhaps because deriving estimates for
the two-stage inactivation model were computationally
demanding prior to the availability of desktop computers,
the two-stage approach has not been widely used to
describe the kinetics of microbial inactivation. For example,
there are no estimates of UV254 inactivation of BVDV,
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Figure 1 Influenza virus: Linear regression (lack-of-fit P = 0Æ0009,
k = )0Æ0124), two-stage inactivation (lack-of-fit P = 0Æ7146,
k1 = )0Æ0651, k2 = )0Æ00552). ( ) One-stage inactivation curve and
( ) Two-stage inactivation curve.
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Figure 2 Porcine respiratory and reproductive syndrome virus: Linear
regression (lack-of-fit P = 0Æ0002, k = )0Æ0258), two-stage inactiva-
tion (lack-of-fit P = 0Æ0734, k1 = )0Æ4995, k2 = )0Æ0143). ( )
One-stage inactivation curve and ( ) Two-stage inactivation curve.
Table 1 Parameter estimates and lack-of-fit-test results for two inactivation models
Influenza virus* PRRSV BVDV Reovirus§
One-stage inactivation model
Intercept 4Æ9474 4Æ4367 7Æ1911 9Æ1991
Inactivation rate (K) )0Æ0124 )0Æ0258 )0Æ0188 )0Æ0066
Lack-of-fit-test P-value 0Æ0009 0Æ0002 <0Æ0001 0Æ0410
Two-stage inactivation model–
Intercept 5Æ7970 4Æ7979 8Æ4495 9Æ3996
Susceptible population proportion (1 ) f) 0Æ988 0Æ941 0Æ999 0Æ873
(K1) Inactivation rate (1 ) f) )0Æ0651 )0Æ4995 )0Æ0663 )0Æ0142
Resistant population proportion (f) 0Æ012 0Æ059 0Æ001 0Æ127
(K2) Inactivation rate (f) )0Æ00552 )0Æ0143 )0Æ00948 )0Æ00347
Lack-of-fit-test P-value 0Æ7146 0Æ0734 0Æ2227 0Æ2807
BVDV, bovine viral diarrhoea virus; PRRSV, porcine respiratory and reproductive syndrome virus.
*Influenza A ⁄ Swine ⁄ Iowa ⁄ 73 (H1N1) provided by USDA: National Veterinary Service Laboratories, Ames, IA.
PRRSV type 2 (isolate MN-184) provided by Dr Scott Dee, University of Minnesota, St Paul, MN.
BVDV type 2 (Singer strain) provided by Dr J. Ridpath, USDA: National Animal Disease Center, Ames, IA.
§Reovirus strain T3DC provided by Dr Cathy Miller, Iowa State University, Ames, IA.
–Kowalski et al., 2001.
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PRRSV, reovirus strain T3DC and influenza virus using the
two-stage analysis with which to make comparisons to the
results reported herein. However, our population propor-
tions are in agreement with those hypothesized by Hiatt
(1964) and demonstrated by Riley and Kaufman (1972).
Overall, this study supported the validity of the
two-stage approach as a method for evaluating UV254
inactivation kinetics. In addition, these results provide
guidelines to persons responsible for the prevention and
control of these agents in the environment. Importantly,
a comparison of one-stage and two-stage inactivation
models using experimental data showed that inactivation
of the viruses in the study was a two-stage process, as
confirmed by a statistical lack-of-fit test.
Acknowledgements
This project was funded in part by Check-Off dollars
through the National Pork Board and the PRRS CAP,
USDA NIFA Award 2008-55620-19132.
References
Brickner, P.W., Vincent, R.L., First, M., Nardell, E., Murray, M.
and Kaufman, W. (2003) The application of ultraviolet
germicidal irradiation to control transmission of airborne
disease: bioterrorism countermeasure. Public Health Rep
11, 99–114.
Chang, J.C.H., Ossoff, S.F., Lobe, D.C., Dorfman, M.H.,
Dumiais, C.M., Qualls, R.G. and Johnson, J.D. (1985) UV
inactivation of pathogenic and indicator microorganisms.
Appl Environ Microbiol 49, 1361–1365.
Goldberg, L.J., Watkins, H.M.S., Boerke, E.E. and Chatigny,
M.A. (1958) The use of a rotating drum for the study of
aerosols over extended periods of time. Am J Hyg 68, 86–93.
Hiatt, C.W. (1964) Kinetics of the inactivation of viruses.
Bacteriol Rev 28, 150–163.
Hijnen, W.A., Beerendonk, E.F. and Medema, G.J. (2006)
Inactivation credit of UV radiation for viruses, bacteria
and protozoan (oo)cysts in water: a review. Water Res 40,
3–22.
Hubert, J.J. (1992) Other methods for estimating LC50. In
Bioassays, 3rd edn pp. 60–81 Dubuque, IA: Kendall ⁄Hunt
Publishing Co.
Jagger, J. (1967) Conduct of experiments. In Introduction to
Research in Ultraviolet Photobiology ed. McElroy, W.D. and
Swanson, C.P. pp. 50–96 Englewood Cliffs, NJ: Prentice-
Hall, Inc.
Kowalski, W.J., Bahnfleth, W.P., Witham, D., Severin, B.F. and
Whittam, T.S. (2001) Mathematical modeling of UVGI for
air disinfection. Quant Microbiol 2, 249–270.
Nibert, M.L. and Fields, B.N. (1992) A carboxy-terminal
fragment of protein mu 1 ⁄mu 1C is present in infectious
subvirion particles of mammalian reoviruses and is pro-
posed to have a role in penetration. J Virol 66, 6408–6418.
Qin, Q., Hastings, C. and Miller, C.L. (2009) Mammalian
orthoreovirus particles induce and are recruited into stress
granules at early times postinfection. J Virol 83, 11090–
11101.
Riley, R.L. and Kaufman, J.E. (1972) Effect of relative humidity
on the inactivation of airborne serratia marcescens by
ultraviolet radiation. Appl Microbiol 23, 1113–1120.
Rubin, A.J. and Elmaraghy, G.A. (1977) Studies on the toxicity
of ammonia, nitrate and their mixture to guppy fry. Water
Res 11, 927–935.
Thurston-Enriquez, J.A., Haas, C.N., Jacangelo, J., Riley, K.
and Gerba, C.P. (2003) Inactivation of feline calicivirus
and adenovirus type 40 by UV radiation. Appl Environ
Microbiol 69, 577–582.
10
BV
DV
 T
CI
D 5
0 
pe
r m
l
9
8
7
6
5
4
3
2
0 50 100 150 200 250 300
UV254 exposure (mJ cm–2)
Figure 3 Bovine viral diarrhoea virus: Linear regression (lack-of-fit
P £ 0Æ0001, k = )0Æ0188), two-stage inactivation (lack-of-fit P = 0Æ2227,
k1 = )0Æ0663, k2 = )0Æ00948). ( ) One-stage inactivation curve
and ( ) Two-stage inactivation curve.
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Figure 4 Reovirus: Linear regression (lack-of-fit P £ 0Æ0410, k = )0Æ0066),
two-stage inactivation (lack-of-fit P = 0Æ2807, k1 = )0Æ0142,
k2 = )0Æ0035). ( ) One-stage inactivation curve and ( ) Two-
stage inactivation curve.
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